These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 18794428)
1. Importance of sentinel lymph node biopsy in patients with thin melanoma. Wright BE; Scheri RP; Ye X; Faries MB; Turner RR; Essner R; Morton DL Arch Surg; 2008 Sep; 143(9):892-9; discussion 899-900. PubMed ID: 18794428 [TBL] [Abstract][Full Text] [Related]
2. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606 [TBL] [Abstract][Full Text] [Related]
3. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031 [TBL] [Abstract][Full Text] [Related]
4. Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma? Yao KA; Hsueh EC; Essner R; Foshag LJ; Wanek LA; Morton DL Ann Surg; 2003 Nov; 238(5):743-7. PubMed ID: 14578738 [TBL] [Abstract][Full Text] [Related]
5. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma. Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694 [TBL] [Abstract][Full Text] [Related]
6. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Scheri RP; Essner R; Turner RR; Ye X; Morton DL Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. Jones EL; Jones TS; Pearlman NW; Gao D; Stovall R; Gajdos C; Kounalakis N; Gonzalez R; Lewis KD; Robinson WA; McCarter MD JAMA Surg; 2013 May; 148(5):456-61. PubMed ID: 23325294 [TBL] [Abstract][Full Text] [Related]
12. Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis? Han D; Han G; Morrison S; Leong SP; Kashani-Sabet M; Vetto J; White R; Schneebaum S; Pockaj B; Mozzillo N; Sondak VK; Zager JS Surgery; 2020 Sep; 168(3):518-526. PubMed ID: 32669204 [TBL] [Abstract][Full Text] [Related]
13. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients. Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514 [TBL] [Abstract][Full Text] [Related]
14. [Prognosis after sentinel node biopsy in malignant melanoma]. Lock-Andersen J; Horn J; Sjøstrand H Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370 [TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma. Fincher TR; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; O'Brien JC; Kuhn JA Am J Surg; 2003 Dec; 186(6):675-81. PubMed ID: 14672778 [TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience. Fairbairn NG; Orfaniotis G; Butterworth M J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution. Avilés-Izquierdo JA; Nieto-Benito LM; Lázaro-Ochaita P; Escat-Cortés JL; Marquez-Rodas I; Mercader-Cidoncha E Clin Transl Oncol; 2020 Sep; 22(9):1611-1618. PubMed ID: 32065344 [TBL] [Abstract][Full Text] [Related]
18. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. van Akkooi AC; Nowecki ZI; Voit C; Schäfer-Hesterberg G; Michej W; de Wilt JH; Rutkowski P; Verhoef C; Eggermont AM Ann Surg; 2008 Dec; 248(6):949-55. PubMed ID: 19092339 [TBL] [Abstract][Full Text] [Related]
19. Risk factors and patterns of recurrence after sentinel lymph node biopsy for thin melanoma. Kim D; Chu S; Khan AU; Compres EV; Zhang H; Gerami P; Wayne JD Arch Dermatol Res; 2022 Apr; 314(3):285-292. PubMed ID: 33884478 [TBL] [Abstract][Full Text] [Related]
20. Sentinel node tumor burden in prediction of prognosis in melanoma patients. Palve J; Ylitalo L; Luukkaala T; Jernman J; Korhonen N Clin Exp Metastasis; 2020 Apr; 37(2):365-376. PubMed ID: 32076905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]